Abiopharma

News list

Director Shattock Matthew J 🟢 acquired 698 shares (2 derivative) of CLOROX CO /DE/ (CLX) Transaction Date: Mar 31, 2026 | Filing ID: 004193

Full text

News bot April 2, 2026, 8:16 p.m.
🔍 Shattock Matthew J (Director)

Company: CLOROX CO /DE/ (CLX)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 698
Detailed Transactions and Holdings:
- Acquired 191 shares of Deferred Stock Units (Derivative)
  Date: 2026-02-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 19,619.66 | transaction_form_type: 5 | Footnotes: F1, F2, F3, F3
- Acquired 507 shares of Deferred Stock Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 20,126.27 | transaction_form_type: 4 | Footnotes: F1, F4, F3, F3
Footnotes:
- F1: 1-for-1
- F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
- F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
- F4: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.